Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000183

President-Protein Sciences sold 23,637 shares at an average $267.73 ($6,328,242)

  • President-Protein Sciences acquired 23,637 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eansor Norman David President-Protein Sciences 2020-05-21 Option exercise +11,037 $94.35 $1,041,341 11,037 D: show line 1 in the form
Eansor Norman David President-Protein Sciences 2020-05-21 Sale −10,137 $267.37 $2,710,320 900 D: show line 2 in the form
Eansor Norman David President-Protein Sciences 2020-05-21 Sale −900 $268.89 $241,997 0 D: show line 3 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Option exercise +3,963 $94.35 $373,909 3,963 D: show line 4 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Option exercise +8,637 $108.49 $937,028 12,600 D: show line 5 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Sale −7,676 $267.63 $2,054,290 4,924 D: show line 6 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Sale −4,924 $268.41 $1,321,636 0 D: show line 7 in the form
Open-market sales · 23,637 sh · avg $267.73 · $6,328,242

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eansor Norman David President-Protein Sciences 2020-05-21 Option exercise · Stock Options (Right to Buy) −11,037 3,963 D: show line 8 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Option exercise · Stock Options (Right to Buy) −3,963 0 D: show line 9 in the form
Eansor Norman David President-Protein Sciences 2020-05-22 Option exercise · Stock Options (Right to Buy) −8,637 11,357 D: show line 10 in the form
Loading xslF345X03/edgar.xml…